Latest News for PPH
Simplify Health Care ETF has a higher expense ratio and a lower dividend yield than VanEck Pharmaceutical ETF. VanEck Pharmaceutical ETF maintains a more concentrated portfolio focused exclusively on global pharmaceutical giants.
Trump's 100% pharma tariff is reshaping the drug industry. Here's how the key pharma ETFs could be affected.
Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the VanEck Pharmaceutical ETF (PPH), a passively managed exchange traded fund launched on December 20, 2011.
The VanEck Pharmaceutical ETF offers a lower expense ratio of 0.36% compared to 0.58% for the Invesco Pharmaceuticals ETF. The Invesco Pharmaceuticals ETF has delivered a higher 1-year total return of 41% relative to 31% for the VanEck fund.
PPH offers higher income and lower volatility, while BBH delivers stronger growth but with deeper drawdowns.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for PPH.
Senate Trading
No Senate trades found for PPH.
U.S. House Trading
No House trades found for PPH.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.